Literature DB >> 21471433

Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission.

Jared M Baeten1, Erin Kahle, Jairam R Lingappa, Robert W Coombs, Sinead Delany-Moretlwe, Edith Nakku-Joloba, Nelly R Mugo, Anna Wald, Lawrence Corey, Deborah Donnell, Mary S Campbell, James I Mullins, Connie Celum.   

Abstract

High plasma HIV-1 RNA concentrations are associated with an increased risk of HIV-1 transmission. Although plasma and genital HIV-1 RNA concentrations are correlated, no study has evaluated the relationship between genital HIV-1 RNA and the risk of heterosexual HIV-1 transmission. In a prospective study of 2521 African HIV-1 serodiscordant couples, we assessed genital HIV-1 RNA quantity and HIV-1 transmission risk. HIV-1 transmission linkage was established within the partnership by viral sequence analysis. We tested endocervical samples from 1805 women, including 46 who transmitted HIV-1 to their partner, and semen samples from 716 men, including 32 who transmitted HIV-1 to their partner. There was a correlation between genital and plasma HIV-1 RNA concentrations: For endocervical swabs, Spearman's rank correlation coefficient ρ was 0.56, and for semen, ρ was 0.55. Each 1.0 log(10) increase in genital HIV-1 RNA was associated with a 2.20-fold (for endocervical swabs: 95% confidence interval, 1.60 to 3.04) and a 1.79-fold (for semen: 95% confidence interval, 1.30 to 2.47) increased risk of HIV-1 transmission. Genital HIV-1 RNA independently predicted HIV-1 transmission risk after adjusting for plasma HIV-1 quantity (hazard ratio, 1.67 for endocervical swabs and 1.68 for semen). Seven female-to-male and four male-to-female HIV-1 transmissions (incidence <1% per year) occurred from persons with undetectable genital HIV-1 RNA, but in all 11 cases, plasma HIV-1 RNA was detected. Thus, higher genital HIV-1 RNA concentrations are associated with greater risk of heterosexual HIV-1 transmission, and this effect was independent of plasma HIV-1 concentrations. These data suggest that HIV-1 RNA in genital secretions could be used as a marker of HIV-1 sexual transmission risk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21471433      PMCID: PMC3087186          DOI: 10.1126/scitranslmed.3001888

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  33 in total

1.  Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.

Authors:  Susan M Graham; Sarah E Holte; Norbert M Peshu; Barbra A Richardson; Dana D Panteleeff; Walter G Jaoko; Jeckoniah O Ndinya-Achola; Kishorchandra N Mandaliya; Julie M Overbaugh; R Scott McClelland
Journal:  AIDS       Date:  2007-02-19       Impact factor: 4.177

2.  Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation.

Authors:  Prameet M Sheth; Ali Danesh; Anthony Sheung; Anuradha Rebbapragada; Kamnoosh Shahabi; Colin Kovacs; Roberta Halpenny; David Tilley; Tony Mazzulli; Kelly MacDonald; David Kelvin; Rupert Kaul
Journal:  J Infect Dis       Date:  2005-11-21       Impact factor: 5.226

3.  The origins of sexually transmitted HIV among men who have sex with men.

Authors:  David M Butler; Wayne Delport; Sergei L Kosakovsky Pond; Malcolm K Lakdawala; Pok Man Cheng; Susan J Little; Douglas D Richman; Davey M Smith
Journal:  Sci Transl Med       Date:  2010-02-10       Impact factor: 17.956

4.  Exposure to HIV-1 during delivery and mother-to-child transmission.

Authors:  P Gaillard; C Verhofstede; F Mwanyumba; P Claeys; V Chohan; K Mandaliya; J Bwayo; J Plum; M Temmerman
Journal:  AIDS       Date:  2000-10-20       Impact factor: 4.177

5.  Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men.

Authors:  David M Butler; Davey M Smith; Edward R Cachay; George K Hightower; Charles Thomas Nugent; Douglas D Richman; Susan J Little
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

Review 6.  The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission.

Authors:  R Kaul; C Pettengell; P M Sheth; S Sunderji; A Biringer; K MacDonald; S Walmsley; A Rebbapragada
Journal:  J Reprod Immunol       Date:  2007-03-28       Impact factor: 4.054

7.  Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial.

Authors:  Jared M Baeten; Lara B Strick; Aldo Lucchetti; William L H Whittington; Jorge Sanchez; Robert W Coombs; Amalia Magaret; Anna Wald; Lawrence Corey; Connie Celum
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226

8.  Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection.

Authors:  Christopher D Pilcher; George Joaki; Irving F Hoffman; Francis E A Martinson; Clement Mapanje; Paul W Stewart; Kimberly A Powers; Shannon Galvin; David Chilongozi; Syze Gama; Matthew A Price; Susan A Fiscus; Myron S Cohen
Journal:  AIDS       Date:  2007-08-20       Impact factor: 4.177

9.  HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men.

Authors:  Richard A Zuckerman; Aldo Lucchetti; William L H Whittington; Jorge Sánchez; Robert W Coombs; Amalia Magaret; Anna Wald; Lawrence Corey; Connie Celum
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

10.  Intermittent shedding of human immunodeficiency virus in semen: implications for sexual transmission.

Authors:  J N Krieger; R W Coombs; A C Collier; D D Ho; S O Ross; J E Zeh; L Corey
Journal:  J Urol       Date:  1995-09       Impact factor: 7.450

View more
  149 in total

1.  Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract.

Authors:  Sara Gianella; Sheldon R Morris; Christy Anderson; Celsa A Spina; Milenka V Vargas; Jason A Young; Douglas D Richman; Susan J Little; Davey M Smith
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

2.  ART influences HIV persistence in the female reproductive tract and cervicovaginal secretions.

Authors:  Rikke Olesen; Michael D Swanson; Martina Kovarova; Tomonori Nochi; Morgan Chateau; Jenna B Honeycutt; Julie M Long; Paul W Denton; Michael G Hudgens; Amy Richardson; Martin Tolstrup; Lars Østergaard; Angela Wahl; J Victor Garcia
Journal:  J Clin Invest       Date:  2016-02-08       Impact factor: 14.808

3.  Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy.

Authors:  G Matusali; N Dereuddre-Bosquet; A Le Tortorec; M Moreau; A-P Satie; D Mahé; P Roumaud; O Bourry; N Sylla; S Bernard-Stoecklin; A Pruvost; R Le Grand; N Dejucq-Rainsford
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

4.  Antiretroviral treatment interruptions predict female genital shedding of genotypically resistant HIV-1 RNA.

Authors:  Susan M Graham; Zahra Jalalian-Lechak; Juma Shafi; Vrasha Chohan; Ruth W Deya; Walter Jaoko; Kishor N Mandaliya; Norbert M Peshu; Julie Overbaugh; R Scott McClelland
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

Review 5.  Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa.

Authors:  Holly Janes; Lawrence Corey; Gita Ramjee; Lindsay N Carpp; Carl Lombard; Myron S Cohen; Peter B Gilbert; Glenda E Gray
Journal:  AIDS Res Hum Retroviruses       Date:  2018-06-19       Impact factor: 2.205

Review 6.  Antiretrovirals and safer conception for HIV-serodiscordant couples.

Authors:  Lynn T Matthews; Jennifer A Smit; Susan Cu-Uvin; Deborah Cohan
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

Review 7.  Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS.

Authors:  Maria M Bednar; Christa Buckheit Sturdevant; Lauren A Tompkins; Kathryn Twigg Arrildt; Elena Dukhovlinova; Laura P Kincer; Ronald Swanstrom
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

8.  HIV-1-RNA Decay and Dolutegravir Concentrations in Semen of Patients Starting a First Antiretroviral Regimen.

Authors:  Arkaitz Imaz; Javier Martinez-Picado; Jordi Niubó; Angela D M Kashuba; Elena Ferrer; Dan Ouchi; Craig Sykes; Nerea Rozas; Laura Acerete; Jordi Curto; Antonia Vila; Daniel Podzamczer
Journal:  J Infect Dis       Date:  2016-08-30       Impact factor: 5.226

Review 9.  Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis.

Authors:  Connie Celum; Jared M Baeten
Journal:  Antivir Ther       Date:  2012-12-07

Review 10.  Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV.

Authors:  Kimberly K Scarsi; Kristin M Darin; Catherine A Chappell; Stephanie M Nitz; Mohammed Lamorde
Journal:  Drug Saf       Date:  2016-11       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.